News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioRestorative Therapies, Inc. Signs Research And Development Agreement With ROHTO Pharmaceutical Co., Ltd.


3/25/2014 9:51:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement (“Agreement”) with Rohto Pharmaceutical Company, Ltd. (“Rohto”). Under the Agreement, BRT has been engaged to provide stem cell research and development services.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES